Eli Lilly also said it has filed for Food and Drug Administration approval of the daily GLP-1 pill, called orforglipron, for ...

India’s growing conversation around Ozempic sits at a tricky crossroads, between rising obesity rates and a food culture ...

The average weight increase after 52 weeks for Wegovy patients was 2 pounds, whereas Zepbound patients gained 11 pounds. Eli ...

Discover how Ram Kapoor, renowned actor from ‘Bade Achhe Lagte Hain’, transformed his life by losing 55 kg and adopting a ...

The diabetes medication semaglutide has recently become a trendy weight loss treatment. But like every drug, there are ...

Weight loss injections have completely altered the landscape of dieting and have helped millions to lose weight. Medications ...

Tirzepatide starts working quickly. You might notice less hunger in a few days or weeks. Average weight loss in 3 weeks is ...

As of February 2025, the semaglutide injection (Ozempic, Wegovy) shortage was resolved. As a result, compounded semaglutide ...

Good news for people on GLP-1 therapy who hate needles: Trial data out this week shows that an experimental pill developed by ...

The filing comes as Novo fights tooth-and-nail with rival Lilly to regain its footing at the top of the weight loss market.

Policy swings have made it a slippery year for pharma ...

The weight loss industry is experiencing its most dramatic transformation in decades. What started as a sector dominated by ...